3 Programs

  • First-Line and Maintenance Therapy for Patients with HER2-Positive Metastatic Breast Cancer

    Explore program
    • April 2026 1 ABIM MOC, ABS MOC, CME 46min
      • P
      Dr Loibl
    • April 2026 0.75 ABIM MOC, ABS MOC, CME 30min
      • P
      Dr Loibl
  • Nonmetastatic Non-Small Cell Lung Cancer

    Explore program
    • April 2026 1.25 ABIM MOC, ABS MOC, CME 59min
      • J
      Dr Chaft
  • Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer

    Explore program
    • April 2026 1.25 ABIM MOC, ABS MOC, CME 51min
      • W
      Dr Abida
    • April 2026 0.75 ABIM MOC, ABS MOC, CME 27min
      • W
      Dr Abida